Musculoskeletal Cancers Remote Monitoring and Care
Recruiting now · Not applicable
Conditions studied: Osteosarcoma, Metastatic Bone Disease
In brief
This study aims to evaluate how walking stability and the ability to perform daily activities change during cancer treatment, and whether a smartwatch can detect these changes. The goal is to develop proactive, personalized tools that automatically monitor treatment response and predict potential complications. To support future implementation, the study will assess the feasibility of wearing a smartwatch for at least 12 hours per day, using a mobile application, and completing weekly questionnaires among patients with primary osteosarcoma or metastatic bone disease.
Key facts
- Study ID
- NCT07129226
- Run by
- Case Comprehensive Cancer Center
- People needed
- 60
- Starts
- 2026-02-12
- Expected to finish
- 2026-11-01
- Last updated by the study team
- 2026-08-06
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- primary sarcoma or metastatic bone disease of the lower extremities or pelvis.
- undergoing evaluation for (or have recently undergone) non-surgical or surgical intervention.
- recent history of home ambulation.
You may not qualify if…
- under 18 years of age at the time of study enrolment
- inability to comprehend consent form and give informed consent
- no access to a smartphone (iOS or Android) to interface with watch application
- tattoos located on the skin of the wrist or forearm where the watch will be placed or other skin conditions preventing adequate sensor function
- amputation or other disease of the arm or skin that prevents wear of a smart-watch device
- inability to tolerate watch for at least 12 hours per day on at least 80% of days in a four-week period
Where it is running
- Case Comprehensive Cancer Center, Cleveland Clinic Foundation — Cleveland, Ohio, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.